IBDEI01R ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,348,0)
 ;;=307.51^^2^25^2
 ;;^UTILITY(U,$J,358.3,348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,348,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,348,1,5,0)
 ;;=5^Bulemia
 ;;^UTILITY(U,$J,358.3,348,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,349,0)
 ;;=307.50^^2^25^3
 ;;^UTILITY(U,$J,358.3,349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,349,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,349,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,349,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,350,0)
 ;;=333.99^^2^26^1
 ;;^UTILITY(U,$J,358.3,350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,350,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,350,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,350,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,351,0)
 ;;=332.0^^2^26^3
 ;;^UTILITY(U,$J,358.3,351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,351,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,351,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,351,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,352,0)
 ;;=333.79^^2^26^2
 ;;^UTILITY(U,$J,358.3,352,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,352,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,352,1,5,0)
 ;;=5^Acute Dystonia
 ;;^UTILITY(U,$J,358.3,352,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,353,0)
 ;;=333.85^^2^26^4
 ;;^UTILITY(U,$J,358.3,353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,353,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,353,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,353,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,354,0)
 ;;=V87.39^^2^27^1
 ;;^UTILITY(U,$J,358.3,354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,354,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,354,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,354,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,355,0)
 ;;=310.0^^2^28^2
 ;;^UTILITY(U,$J,358.3,355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,355,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,355,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,355,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,356,0)
 ;;=310.1^^2^28^3
 ;;^UTILITY(U,$J,358.3,356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,356,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,356,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;^UTILITY(U,$J,358.3,356,2)
 ;;=^331953
 ;;^UTILITY(U,$J,358.3,357,0)
 ;;=310.2^^2^28^4
 ;;^UTILITY(U,$J,358.3,357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,357,1,2,0)
 ;;=2^310.2
 ;;^UTILITY(U,$J,358.3,357,1,5,0)
 ;;=5^Postconcussion Syndrome
 ;;^UTILITY(U,$J,358.3,357,2)
 ;;=^265160
 ;;^UTILITY(U,$J,358.3,358,0)
 ;;=310.81^^2^28^5
 ;;^UTILITY(U,$J,358.3,358,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,358,1,2,0)
 ;;=2^310.81
 ;;^UTILITY(U,$J,358.3,358,1,5,0)
 ;;=5^Pseudobulbar Affect
 ;;^UTILITY(U,$J,358.3,358,2)
 ;;=^340506
 ;;^UTILITY(U,$J,358.3,359,0)
 ;;=310.89^^2^28^1
 ;;^UTILITY(U,$J,358.3,359,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,359,1,2,0)
 ;;=2^310.89
 ;;^UTILITY(U,$J,358.3,359,1,5,0)
 ;;=5^Brain Damage D/O,Oth Spec
 ;;^UTILITY(U,$J,358.3,359,2)
 ;;=^268320
 ;;^UTILITY(U,$J,358.3,360,0)
 ;;=99212^^3^29^2
 ;;^UTILITY(U,$J,358.3,360,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,360,1,1,0)
 ;;=1^PROBLEM FOCUSED
 ;;^UTILITY(U,$J,358.3,360,1,2,0)
 ;;=2^99212
 ;;^UTILITY(U,$J,358.3,361,0)
 ;;=99213^^3^29^3
 ;;^UTILITY(U,$J,358.3,361,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,361,1,1,0)
 ;;=1^EXPANDED PROBLEM FOCUSED
 ;;^UTILITY(U,$J,358.3,361,1,2,0)
 ;;=2^99213
 ;;^UTILITY(U,$J,358.3,362,0)
 ;;=99214^^3^29^4
 ;;^UTILITY(U,$J,358.3,362,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,362,1,1,0)
 ;;=1^DETAILED
 ;;^UTILITY(U,$J,358.3,362,1,2,0)
 ;;=2^99214
 ;;^UTILITY(U,$J,358.3,363,0)
 ;;=99215^^3^29^5
